In surgery for localized muscle-invasive bladder cancer, extended lymph node removal offers no survival benefit but does ...
The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher rate of grade 3-4 adverse events and an increased risk of death in the 90 days after surgery. The findings, published in NEJM, should …